What is ARMK's health score?

Aramark (ARMK) has a TradeApes health score of 36 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ARMK's estimated fair value?

Based on our 5-year discounted cash flow model, Aramark's estimated fair value is $35.79 per share, representing a -33.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ARMK undervalued or overvalued?

Our model currently rates ARMK as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ARMK... Refresh in a moment for the full analysis.

Aramark (ARMK)

Consumer Cyclical Overvalued low weak

$53.54

Updated: 2026-06-04

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

20 Stressed

Relative Value

10 Stressed

Capital Allocation

55 Mixed

Risk

60 Healthy

Est. Fair Value $35.79

DCF Upside -33.2%

Sector Rank #217 of 3253

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.